NON-BINDING TERM SHEET

Sigma Financial Technologies, Inc.
Series B Preferred Stock Financing

Date: November 1, 2024

This term sheet summarizes the principal terms of the proposed Series B Preferred Stock financing of Sigma Financial Technologies, Inc. (the "Company"). This term sheet is for discussion purposes only and does not constitute a legally binding commitment. Binding obligations will only result from the execution of definitive agreements.

OFFERING TERMS

Issuer:                     Sigma Financial Technologies, Inc. (Delaware C-Corp)

Investors:                  Phoenix Ventures Fund III, L.P. ("Lead Investor")
                           Existing investors pro-rata participation rights

Amount:                     $35,000,000

Security:                   Series B Preferred Stock ("Series B")

Pre-Money Valuation:        $115,000,000  

Post-Money Valuation:       $150,000,000

Price Per Share:            $2.1739 (based on 68,950,000 shares outstanding pre-financing)

Closing Date:               On or before December 20, 2024

CAPITALIZATION

                                    Shares              %           
Common Stock:                       55,000,000         36.7%
Series A Preferred:                 13,950,000          9.3%
Employee Option Pool (reserved):    10,000,000          6.7%
Series B Preferred (new):           16,100,000         10.7%
Post-Series B Option Pool:          15,000,000         10.0%
FULLY DILUTED:                     110,050,000        100.0%

DIVIDEND PROVISIONS

Dividends on Series B will accrue at 8% per annum on a non-cumulative basis, payable when and if declared by the Board. Dividends on Series A will continue at 6% per annum. Common stock may receive dividends only after Series B and Series A preferred dividends are paid in full.

LIQUIDATION PREFERENCE

In a liquidation event (merger, acquisition, sale of substantially all assets, or winding up):

Senior Liquidation Preference (distributed in order):
1. Series B holders receive 1.5x original purchase price ($52.5M) plus accrued but unpaid dividends
2. Series A holders receive 1.0x original purchase price ($30.3M) plus accrued but unpaid dividends
3. Remaining proceeds distributed pro-rata among all stockholders on an as-converted basis

Participating Rights: Series B participates pro-rata with common after receiving liquidation preference. Series A is non-participating.

Cap on Participation: Series B participation capped at 3x original purchase price total return.

Deemed Liquidation: Any merger, acquisition, or sale of >50% of voting power is treated as liquidation event, subject to approval of holders of majority of Series B.

CONVERSION

Each share of Series B converts into Common at any time at holder's option. Initial conversion ratio is 1:1, subject to anti-dilution adjustments.

Automatic conversion upon (i) qualified IPO with $200M+ valuation and $50M+ gross proceeds, or (ii) written consent of holders of 66.7% of Series B.

ANTI-DILUTION PROTECTION

Series B: Weighted average anti-dilution protection for dilutive issuances below Series B price.

Series A: Existing weighted average anti-dilution protection continues.

Standard carve-outs apply: employee option pool issuances, stock splits, dividends, strategic partnerships approved by Board, equipment leasing, acquisitions approved by Board.

VOTING RIGHTS

Series B votes with Common on an as-converted basis on all matters except as required by law or these terms.

Board composition: 7 seats
- 2 seats: Series B designees (Phoenix Ventures)  
- 1 seat: Series A designee (Accel Partners)
- 2 seats: Common designees (CEO + Founder)
- 2 seats: Independent directors mutually agreed

Board observer rights: Each investor holding >10% has observer rights.

PROTECTIVE PROVISIONS

Series B consent (majority) required for:
- Amendments to Certificate or Bylaws adversely affecting Series B
- Issuance of stock senior to or pari passu with Series B
- Redemption or repurchase of stock (except employee buybacks per plan)
- Declaration of dividends on Common
- Incurrence of debt >$5M (excluding equipment leasing)
- Sale, exclusive license, or transfer of material IP
- Related party transactions >$250K
- Annual operating budget and material amendments
- Hiring or termination of CEO
- Company acquisition, merger, or sale of substantial assets
- Transactions outside ordinary course >$3M

Series A existing protective provisions continue for matters affecting Series A.

DRAG-ALONG RIGHTS

Holders of >66.7% of Preferred (voting together) + Common Board designees may require all stockholders to approve Company sale or deemed liquidation on same terms.

Carve-outs: Requires at least 1x return to Common on as-converted basis.

INFORMATION RIGHTS

Investors holding >5% receive:
- Monthly financial statements (unaudited) within 15 days of month-end
- Quarterly financial statements (unaudited) within 30 days of quarter-end  
- Annual financial statements (audited) within 90 days of year-end
- Annual operating budget at least 30 days before fiscal year start
- Prompt notice of material events

Rights terminate upon IPO or acquisition.

REGISTRATION RIGHTS

Demand Rights: Series B holders with >33% of Series B may require registration of shares on two occasions, provided anticipated aggregate offering >$15M.

S-3 Rights: Holders of >10% may require up to two S-3 registrations per year if available, with $5M minimum.

Piggyback Rights: Pro-rata participation in Company-initiated registrations.

Lock-up: 180 days post-IPO; officers/directors lock-up on same terms.

Standard provisions regarding expenses, indemnification, underwriting arrangements.

PRO-RATA RIGHTS

Major Investors (holders of >5% on as-converted basis) have pro-rata right to participate in future equity financings to maintain ownership percentage.

Carry-forward rights if not fully exercised.

RIGHT OF FIRST REFUSAL / CO-SALE

Company and then Major Investors have ROFR on proposed transfers of Common by Founders.

Co-sale rights allow Major Investors to participate pro-rata in Founder transfers not purchased via ROFR.

Standard exclusions: estate planning, employee transfers per plan, transfers to affiliates.

Rights terminate upon IPO.

REDEMPTION

Series B holders may elect redemption starting 7 years after Series B closing. Redemption in three annual installments at original purchase price plus accrued dividends. Company may prepay at any time without penalty.

EMPLOYEE OPTION POOL

Post-Series B option pool of 15M shares (13.6% fully diluted). Pool created prior to Series B pricing. 

Standard 4-year vesting with 1-year cliff for new grants.

Acceleration provisions: 50% vesting on Company sale if terminated without cause within 12 months; 100% for CEO on sale.

FOUNDER VESTING

Founders' unvested shares subject to repurchase by Company at cost if terminated for cause or resign without good reason. 

Existing vesting schedules: 
- CEO (Sarah Park): 75% vested, remainder vests quarterly through June 2026
- CTO (Alex Chen): 60% vested, remainder vests quarterly through March 2027

Accelerated vesting: 50% of unvested shares vest on Company sale if Founder terminated without cause within 12 months; 100% for CEO.

NO-SHOP / CONFIDENTIALITY

Company agrees to 45-day exclusivity period from term sheet execution (through December 15, 2024).

Company will not solicit or engage in discussions with other investors regarding equity financing during exclusivity.

Terms of this financing are confidential, subject to standard exceptions.

CONDITIONS TO CLOSING

- Execution of definitive Stock Purchase Agreement, Amended & Restated Certificate of Incorporation, Amended & Restated Investors' Rights Agreement, Right of First Refusal & Co-Sale Agreement, and Voting Agreement
- Satisfactory completion of legal, financial, technical, and commercial due diligence  
- No Material Adverse Change in business, operations, or financial condition
- Key employee retention agreements executed (CEO, CTO, CFO, VP Eng)
- Qualification of shares under applicable securities laws
- Board approval and stockholder approval (as required)
- Existing Series A investors waiving any ROFR or preemptive rights or participating pro-rata

EXPENSES

Company will pay Lead Investor's reasonable legal fees and expenses up to $75,000 upon closing.

If transaction does not close due to Company breach or termination without cause, Company will reimburse up to $50,000 in investor legal fees.

USE OF PROCEEDS

Estimated allocation of $35M:
- Product development (payments platform v2.0): $12M
- Sales & marketing (enterprise go-to-market): $10M  
- International expansion (UK, EU): $6M
- Working capital & general corporate purposes: $5M
- Strategic hires (VP Sales, VP Product, Head of Intl): $2M

BUSINESS OVERVIEW

Company: Sigma Financial Technologies, Inc.
Founded: 2019
Headquarters: Austin, TX
Employees: 127

Description: B2B payments automation platform for mid-market companies. SaaS model with usage-based pricing. Integrates with ERPs (NetSuite, SAP, QuickBooks) to automate invoice processing, payment execution, and reconciliation.

Metrics (as of Q3 2024):
- ARR: $18.2M (growing 140% YoY)  
- Customers: 312 (avg 28 employees, $1.5B+ annual revenue)
- Gross Margin: 78%
- Net Dollar Retention: 135%
- Magic Number: 1.2
- Burn Rate: $1.8M/month
- Cash Balance: $4.2M (2.3 months runway)

Management Team:
- Sarah Park, CEO (ex-Stripe, Stanford CS)
- Alex Chen, CTO (ex-Square, MIT)
- Maria Rodriguez, CFO (ex-Brex, Wharton MBA)

---

LEAD INVESTOR:                          COMPANY:

Phoenix Ventures Fund III, L.P.         Sigma Financial Technologies, Inc.

By: _____________________________        By: _____________________________
Name: David Liu                          Name: Sarah Park
Title: Managing Partner                 Title: Chief Executive Officer
Date: November 1, 2024                  Date: _______________